AML, ADULT
Clinical trials for AML, ADULT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT trials appear
Sign up with your email to follow new studies for AML, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for older leukemia patients: which chemo combo works best?
Disease control Recruiting nowThis study tests two different chemotherapy combinations in adults aged 55 to 75 with acute myeloid leukemia (AML) who are healthy enough for strong treatment. One group gets venetoclax plus azacitidine, the other gets standard drugs (daunorubicin or idarubicin plus cytarabine). …
Matched conditions: AML, ADULT
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New hope for rare leukemia: targeted combo trial launches
Disease control Recruiting nowThis early-phase trial tests a new drug called revumenib alongside standard chemotherapy and a targeted therapy (midostaurin) for adults with a specific genetic form of acute myeloid leukemia (AML). The goal is to find a safe dose that improves remission rates. About 22 newly dia…
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Richard Stone, MD • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New hope for tough blood cancers: experimental drug eganelisib enters human trials
Disease control Recruiting nowThis early-phase trial tests an experimental drug called eganelisib, given alone or with standard chemotherapy (cytarabine), in adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) has returned or not responded to prior treatment. The main goals …
Matched conditions: AML, ADULT
Phase: PHASE1 • Sponsor: Stelexis BioSciences • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New study aims to reduce unnecessary blood transfusions for blood cancer patients in palliative care
Symptom relief Recruiting nowThis study looks at whether using a quality-of-life questionnaire to guide blood transfusions can reduce the number of transfusions for adults with advanced MDS or AML who are receiving palliative care. Participants will be randomly assigned to either the standard hemoglobin-base…
Matched conditions: AML, ADULT
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated May 17, 2026 00:45 UTC
-
French study tracks Real-World success of AML drug ivosidenib
Knowledge-focused Recruiting nowThis study looks back at how well the drug Ivosidenib works for adults with a specific type of acute myeloid leukemia (AML) that has an IDH1 mutation. Researchers will track survival and treatment responses in 250 patients who received the drug through a compassionate use program…
Matched conditions: AML, ADULT
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC